Press releases
- Penumbra, Inc. to Present at the Truist Securities MedTech Conference
- Penumbra, Inc. to Present at the William Blair Growth Stock Conference
- Penumbra, Inc. Reports First Quarter 2024 Financial Results
- Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
- Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
More ▼
Key statistics
As of last trade Penumbra Inc (0P8:DUS) traded at 173.90, 4.13% above its 52-week low of 167.00, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 174.10 |
---|---|
High | 174.10 |
Low | 173.90 |
Bid | 173.65 |
Offer | 176.70 |
Previous close | 174.05 |
Average volume | 0.00 |
---|---|
Shares outstanding | 38.76m |
Free float | 37.28m |
P/E (TTM) | 81.32 |
Market cap | 7.49bn USD |
EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Jun 10 2024 08:10 BST.
More ▼